GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Other Gross PPE

BioNTech SE (XBUL:22UA) Other Gross PPE : лв828 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BioNTech SE Other Gross PPE?

BioNTech SE's Other Gross PPE for the quarter that ended in Dec. 2024 was лв828 Mil.

BioNTech SE's quarterly Other Gross PPE increased from Jun. 2024 (лв2,189 Mil) to Sep. 2024 (лв2,326 Mil) but then declined from Sep. 2024 (лв2,326 Mil) to Dec. 2024 (лв828 Mil).

BioNTech SE's annual Other Gross PPE increased from Dec. 2022 (лв533 Mil) to Dec. 2023 (лв687 Mil) and increased from Dec. 2023 (лв687 Mil) to Dec. 2024 (лв828 Mil).


BioNTech SE Other Gross PPE Historical Data

The historical data trend for BioNTech SE's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Other Gross PPE Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only 328.99 451.61 533.11 687.38 828.31

BioNTech SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 687.38 2,025.56 2,189.04 2,326.08 828.31

BioNTech SE Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


BioNTech SE Business Description

Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines